Effects of bisphosphonates on osteoporosis: Focus on zoledronate
Authors:
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 264, 118681
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Site Specific Effects of Zoledronic Acid during Tibial and Mandibular Fracture RepairPLOS ONE, 2012
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- The effect of zoledronate during bone healingJournal of Orthopaedics and Traumatology, 2010
- Efficacy and Safety of a Once‐Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and OlderJournal of the American Geriatrics Society, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis ManagementMayo Clinic Proceedings, 2009
- A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosisAIDS, 2009
- Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesLeukemia & Lymphoma, 2008
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis StudyJournal of Bone and Mineral Research, 2000